Table 4.

Comparison of safety evaluation, and postoperative hospital stays and costs, n (%)

	UTI (n = 91)	Placebo (n = 90)	P value
Granulocytopenia	8 (8.79)	4 (4.44)	0.240
Abnormal liver enzymes	31 (34.07)	25 (27.77)	0.360
Diarrhea	27 (29.67)	18 (20.00)	0.132
Vomiting	19 (20.88)	11 (12.22)	0.117
Allergies	22 (24.18)	9 (10.00)	0.029
Hospitalization stays, day, mean ± SD	17.8 ± 4.2	19.6 ± 5.3	0.012
Hospitalization costs, CNY, mean ± SD	3.94 ± 0.82	3.82 ± 0.99	0.376

UTI: Ulinastatin.